David Silverman MRCOphth, MSc

David Silverman worked as an ophthalmologist in the UK before joining Quintiles to work in Phase 1 clinical trials. He subsequently spent nearly 6 years at the MHRA as a clinical assessor, reviewing applications and providing scientific advice for ophthalmic medicines for the UK and the EMA; he also served as a UK delegate on the CHMP’s Scientific Advice Working Party. David joined Roche in 2015, to work on ophthalmic global clinical development programs. He is a Fellow of the Faculty of Pharmaceutical Medicine, and has an MSc in Economic Evaluation for Health Technology Assessment from the University of York.